gaap eps
The latest news about gaap eps: headlines, AI summaries and the full story from every source.
- Pelagos Insurance Capital Reports Mixed Q3 2026 Results with Revenue Beat and EPS Miss
- LiveWorld Reports Q3 Revenue of $2.98 Million and GAAP EPS of -$0.01
- Ideal Power Reports Q3 GAAP EPS of -$0.18 and $7,000 in Revenue
- Kardigan, Inc. Reports Q3 GAAP EPS of -$0.64, Exceeding Analyst Expectations
- Artelo Biosciences Reports Third Quarter GAAP EPS of -$3.19
- Pelthos Therapeutics Reports Q3 Earnings with EPS Beat and Significant Revenue Growth
- Grace Therapeutics Reports Q2 GAAP EPS of -$0.11, Exceeding Estimates
- Imunon Reports Third Quarter GAAP EPS of -$0.64, Missing Estimates by $0.06
- Nuwellis Reports Q3 2026 Revenue of $2.21 Million and GAAP EPS of -$5.81
- Nebius Group Reports Q3 Revenue of $980.8M and EPS Beat
- SOLV Energy, Inc. Reports Q3 Revenue Beat Amid GAAP EPS Miss
- Central Puerto Reports Q3 Revenue Growth of 157.6% with GAAP EPS of $0.25
- ASUSTeK Computer Reports Q3 Revenue Growth of 36.3% Year-over-Year
- Investcorp Credit Management BDC Reports Q3 2026 GAAP EPS of -$0.33 and Declining Net Assets
- Teekay Reports Q3 GAAP EPS of $0.68 and 61.5% Year-over-Year Revenue Growth
- Vivani Medical Reports Q3 GAAP EPS of -$0.08, Exceeding Analyst Expectations
- Lakefront Biotherapeutics Reports Q3 Revenue of €26.1M and GAAP EPS of €0.20
- Worksport Reports Third Quarter Financial Results with Revenue and EPS Miss
- Wilmington Capital Management Reports Third Quarter GAAP EPS of C$0.03
- Tree Island Steel Reports Q3 2026 Revenue Growth Amid Slight GAAP Loss
- U.S. Energy Reports Q3 Results with Revenue Beat but Earnings Miss
- Anteris Technologies Global Corp. Reports Q3 Earnings with EPS Beat and Revenue Growth
- Dundee Preference Shares Series 3 Reports Q3 2026 GAAP EPS of $0.53
- Actelis Networks Reports Q3 Revenue Beat Amid Earnings Miss
- Artesian Resources Reports Q3 GAAP EPS of $0.65 and 4.8% Revenue Growth
- Sonoma Pharmaceuticals Reports Q2 Revenue Growth of 28% with Minimal GAAP Loss
- Founder Group Limited Reports 49.5% Year-over-Year Revenue Growth in First Half
- Black Diamond Therapeutics Reports Q3 GAAP EPS of -$0.17 and Strong Cash Position
- Xilio Therapeutics Reports Q3 Earnings Beat on Revenue and EPS
- Digital Ally Reports Q3 Revenue Growth of 58.8% with GAAP EPS of $4.51
- PMV Pharmaceuticals Reports Q3 GAAP EPS of -$0.52, Missing Estimates by $0.18
- Urban One Reports Q3 Revenue of $88 Million and GAAP EPS Loss of $26.39
- BrainsWay Reports Q3 Revenue Beat Amid GAAP EPS Miss
- D-Wave Quantum Reports Q3 Revenue Beat Amidst Slight EPS Miss
- Lithium Argentina Reports Q3 GAAP EPS of $0.08 in Line with Expectations
- Canaan Reports Q3 Earnings Beat with $14.5 Million in Revenue
- Surrozen Reports Q3 GAAP EPS Miss of $9.92
- Mitsui Kinzoku Reports 18.3% Revenue Growth and Updates FY2027 Outlook
- Elmos Semiconductor Reports Q3 Revenue Growth and Reaffirms FY2026 Outlook
- Olympus Reports 12.2% Year-on-Year Revenue Growth in First Half Results
- Plug Power Reports Q3 2026 Revenue Growth and Improved Operational Margins
- Septerna, Inc. Reports Third Quarter GAAP EPS of -$0.57 and Revenue of $18.88M
- Intercorp Financial Services Reports Q3 GAAP EPS of S/14.78
- Infinity Natural Resources Reports Q3 Revenue Beat Amid Earnings Miss
- Xenon Pharmaceuticals Reports Q3 GAAP EPS of -$1.11, Exceeding Estimates
- Mind Medicine Reports Q3 GAAP EPS of -$0.46, Exceeding Analyst Expectations
- ContextLogic Reports Q3 2026 GAAP EPS of -$0.29 and Revenue of $32.2 Million
- Spruce Biosciences Reports Q3 GAAP EPS Miss and Increased Cash Position
- Bicara Therapeutics Reports Q3 GAAP EPS Miss Amid Increasing Cash Reserves
- ImmunityBio Reports Third Quarter Revenue and EPS Misses